A functional p53-responsive intronic promoter is contained within the human mdm2 gene - PubMed (original) (raw)
Comparative Study
. 1995 Jul 25;23(14):2584-92.
doi: 10.1093/nar/23.14.2584.
Affiliations
- PMID: 7651818
- PMCID: PMC307078
- DOI: 10.1093/nar/23.14.2584
Free PMC article
Comparative Study
A functional p53-responsive intronic promoter is contained within the human mdm2 gene
A Zauberman et al. Nucleic Acids Res. 1995.
Free PMC article
Abstract
The mdm2 gene is a target for transcriptional activation by the p53 tumor suppressor gene product. Previous work has revealed that the mouse mdm2 gene contains two promoters: one is located upstream to the gene and is active in the absence of p53, the other resides within the first intron and requires p53 for transcriptional activity. To determine whether this unique promoter activation pattern is biologically important, we investigated the structure and function of the corresponding region of the human mdm2 (hmdm2) gene. We report here that the hmdm2 gene also contains an intronic, p53-dependent promoter. The structural features of this promoter are highly conserved between mouse and man, as opposed to the lack of conservation of the first exon. This promoter is triggered in vivo in the presence of activated wild type p53, leading to the production of novel mRNA species. The intronic hmdm2 promoter contains two tandem p53 binding elements. Deletion analysis suggests that optimal promoter activity requires the simultaneous binding of p53 to both elements; this may serve to prevent premature triggering of the promoter by p53.
Similar articles
- Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
Barak Y, Gottlieb E, Juven-Gershon T, Oren M. Barak Y, et al. Genes Dev. 1994 Aug 1;8(15):1739-49. doi: 10.1101/gad.8.15.1739. Genes Dev. 1994. PMID: 7958853 - Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
Juven T, Barak Y, Zauberman A, George DL, Oren M. Juven T, et al. Oncogene. 1993 Dec;8(12):3411-6. Oncogene. 1993. PMID: 8247544 - The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants.
Brown DR, Deb D, Frum R, Hickes L, Munoz R, Deb S, Deb SP. Brown DR, et al. Int J Oncol. 2001 Mar;18(3):449-59. doi: 10.3892/ijo.18.3.449. Int J Oncol. 2001. PMID: 11179471 - The mdm2 proto-oncogene.
Haines DS. Haines DS. Leuk Lymphoma. 1997 Jul;26(3-4):227-38. doi: 10.3109/10428199709051772. Leuk Lymphoma. 1997. PMID: 9322885 Review.
Cited by
- MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.
Xu E, Zhang J, Chen X. Xu E, et al. Oncogene. 2013 Apr 25;32(17):2169-78. doi: 10.1038/onc.2012.238. Epub 2012 Jun 18. Oncogene. 2013. PMID: 22710720 Free PMC article. - Splicing up mdm2 for cancer proteome diversity.
Okoro DR, Rosso M, Bargonetti J. Okoro DR, et al. Genes Cancer. 2012 Mar;3(3-4):311-9. doi: 10.1177/1947601912455323. Genes Cancer. 2012. PMID: 23150764 Free PMC article. - Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation.
Tarocchi M, Hannivoort R, Hoshida Y, Lee UE, Vetter D, Narla G, Villanueva A, Oren M, Llovet JM, Friedman SL. Tarocchi M, et al. Hepatology. 2011 Aug;54(2):522-31. doi: 10.1002/hep.24413. Epub 2011 Jun 26. Hepatology. 2011. PMID: 21563203 Free PMC article. - The transcription factor p53: not a repressor, solely an activator.
Fischer M, Steiner L, Engeland K. Fischer M, et al. Cell Cycle. 2014;13(19):3037-58. doi: 10.4161/15384101.2014.949083. Cell Cycle. 2014. PMID: 25486564 Free PMC article. - Vitamin D directly regulates Mdm2 gene expression in osteoblasts.
Chen H, Reed G, Guardia J, Lakhan S, Couture O, Hays E, Chandar N. Chen H, et al. Biochem Biophys Res Commun. 2013 Jan 4;430(1):370-4. doi: 10.1016/j.bbrc.2012.11.003. Epub 2012 Nov 10. Biochem Biophys Res Commun. 2013. PMID: 23149414 Free PMC article.
References
- J Mol Biol. 1981 Jan 25;145(3):471-88 - PubMed
- Mol Med. 1995 Jan;1(2):142-52 - PubMed
- Cell. 1990 Aug 24;62(4):671-80 - PubMed
- EMBO J. 1991 Jun;10(6):1565-9 - PubMed
- Mol Cell Biol. 1992 Jun;12(6):2866-71 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous